ReviewFrontiers in immunology2025
Opportunities and challenges harnessing antigen-specific CD4+ regulatory T cells in inflammatory bowel disease.
Jessica Kümmel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it